Business Insider -
25 Jan 2016 06:48

WSJ Theranos has had a fairly quiet 2016 up until now. The controversial blood-testing startup ran into trouble late in 2015 after The Wall Street Journal launched a series of pieces that questioned the company's finger-prick blood testing technology. Now, The Journal reports that the Centers for Medicare and Medicaid Services (one of the federal bodies that regulates laboratory blood tests) found problems with Theranos' laboratory in Newark, California, which could put the company's relationshi...
Share this Article